We have observed
12 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANGIOGENIC AGENT
TETRAHYDROFOLATES IN COMBINATION WITH EGFR-INHIBITORS
ANTI-TUMOR ACTIVITY OF REDUCED FOLATES LIKE METHYLENE-TETRAHYDROFOLATE
BIOSENSOR HAVING NANOSTRUCURED ELECTRODES
METHODS FOR BLADDER CANCER THERAPY USING BACULOVIRAL VECTORS
SUBSTITUTED HETERO-BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
IN VITRO ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY
BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE WITH ANKYLOSING SPONDYLITIS
J-AGGREGATE FORMING NANOPARTICLE